Journal of Infection and Chemotherapy Volume 29 Issue 1 to 12

Journal Spotlight: Journal of Infection and Chemotherapy (JIC)

The Journal of Infection and Chemotherapy (JIC) is an esteemed publication and the official journal of prominent Japanese societies, including the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Infection Prevention and Control. It offers a platform for the dissemination of research, clinical findings, and expert opinions in the field of chemotherapy and infectious diseases. Here’s what makes the JIC stand out:

Scope and Content:

1. Original Papers: JIC welcomes original research papers, both laboratory and clinical, which contribute to the understanding and management of infections. These papers encompass a wide range of topics, including pathogenesis, diagnosis, treatment, and infection control.
2. Case Reports: Clinical case reports are valuable in shedding light on rare or challenging infectious disease cases, sharing experiences, and offering insights into diagnosis and treatment.
3. Notes: Brief research findings or observations that are noteworthy and can potentially guide further investigations.
4. Committee Reports: Insights and recommendations from committees involved in infectious disease management, prevention, and treatment.
5. Surveillance and Guidelines: Information on infection surveillance and guidelines for the prevention and management of infectious diseases.
6. Anticancer Drug Treatment: An intriguing aspect of JIC is its coverage of anticancer drug treatment in the context of infectious diseases. This intersection is of particular interest to researchers and healthcare practitioners.
7. Experimental Studies: Research involving animal models and pharmacokinetics is vital for understanding drug efficacy and safety in the treatment of infections.
8. Epidemiology: Epidemiological studies provide crucial insights into the prevalence, distribution, and determinants of infectious diseases.
9. Clinical Trials: Reports on clinical trials in the field of infectious diseases and chemotherapy are welcomed. These trials are pivotal in advancing treatment modalities.

Global Perspective: While affiliated with Japanese societies, JIC welcomes contributions from all parts of the world. This global perspective ensures that the journal reflects a diverse and comprehensive view of infectious diseases and chemotherapy.

Language: Although affiliated with Japanese societies, the journal primarily publishes content in English, making it accessible to a wide international audience.

The Journal of Infection and Chemotherapy plays a significant role in advancing the knowledge and practice of infectious disease management and chemotherapy, making it a valuable resource for researchers, clinicians, and healthcare professionals worldwide.

Volume 29, Issue 1: Pages 1-118 (January 2023)

Volume 29, Issue 2: Pages 119-238 (February 2023)

Volume 29, Issue 3: Pages 239-374 (March 2023)

Volume 29, Issue 4: Pages 375-436 (April 2023)

Volume 29, Issue 5: Pages 437-564 (May 2023)

Volume 29, Issue 6: Pages 565-636 (June 2023)

Volume 29, Issue 7: Pages 637-730 (July 2023)

Volume 29, Issue 8: Pages 731-832 (August 2023)

Volume 29, Issue 9: Pages 833-936 (September 2023)

Volume 29, Issue 10: Pages 937-1010 (October 2023)

Volume 29, Issue 11: Pages 1011-1090 (November 2023)

Volume 29, Issue 12: Pages 1091-1188 (December 2023)